HIV Management

FDA Approves Bixlenvo, a Once‑Daily Single‑Pill HIV Regimen

The drug gives adults with suppressed virus who cannot take existing one‑pill therapies a simpler, two‑drug daily option that Gilead says will widen treatment choices.